Outcomes of leadless pacemaker implantation in the United States based on sex
- PMID: 39436461
- PMCID: PMC12317866
- DOI: 10.1007/s10840-024-01936-2
Outcomes of leadless pacemaker implantation in the United States based on sex
Abstract
Background: To determine differences in baseline characteristics and outcomes of leadless pacemaker implantation based on sex.
Methods: For the purpose of this study, data were extracted from the National Inpatient Sample database for years 2016-2020. The study group was then stratified based on sex. Baseline characteristics and in-hospital outcomes including complications were then analyzed in each group. Multivariable logistic regression models were created to analyze the association of sex with important outcomes of mortality, major complications (defined as pericardial effusion requiring intervention and any vascular complication), prolonged length of stay (defined as > 6 days), and increased cost of hospitalization (defined as median cost > 34,098$) after leadless pacemaker implantation.
Results: A total of 29,000 leadless pacemakers (n in women = 12,960, 44.7%) were implanted during our study period. Women were found to have an increased burden of co-morbidities as compared to men. In the adjusted analysis, the likelihood of mortality (aOR 1.27, 95% CI 1.14-1.43), major complications (aOR 1.07, 95% CI 0.98-1.18), prolonged length of stay (aOR 1.09, 95% CI 1.04-1.15), and increased hospitalization cost (aOR 1.14, 95% CI 1.08-1.20) were higher in women as compared to men after leadless pacemaker implantation.
Conclusion: Important and significant differences exist in leadless pacemaker implantation in women as compared to men. These findings highlight the need for evaluating etiologies behind such differences with a goal of improving outcomes in all patients after leadless pacemaker implantation.
Keywords: Complications; Leadless; Mortality; Outcomes; Pacemaker; Women.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures
References
-
- Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, Narasimhan C, Steinwender C, Brugada J, Lloyd M, Roberts PR, Sagi V, Hummel J, Bongiorni MG, Knops RE, Ellis CR, Gornick CC, Bernabei MA, Laager V, Stromberg K, Williams ER, Hudnall JH, Ritter P, MicraTranscatheter Pacing Study Group. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374:533–41. - PubMed
-
- Reddy VY, Exner DV, Doshi R, Tomassoni G, Bunch TJ, Estes NAM, Neužil P, Paulin FL, Garcia Guerrero JJ, Cantillon DJ, LEADLESS II Investigators. Primary results on safety and efficacy from the LEADLESS II-phase 2 worldwide clinical trial. JACC Clin Electrophysiol. 2022;8:115–7. - PubMed
-
- Darden D, Duong T, Du C, Munir MB, Han FT, Reeves R, Saw J, Zeitler EP, Al-Khatib SM, Russo AM, Minges KE, Curtis JP, Freeman JV, Hsu JC. Sex differences in procedural outcomes among patients undergoing left atrial appendage occlusion: insights from the NCDR LAAO Registry. JAMA Cardiol. 2021;6:1275–84. - PMC - PubMed
-
- Osman M, Patel B, Munir MB, Kawsara A, Kheiri B, Balla S, Daggubati R, Michos ED, Alkhouli M. Sex-stratified analysis of the safety of percutaneous left atrial appendage occlusion. Catheter Cardiovasc Interv. 2021;97:885–92. - PubMed
-
- Nowak B, Misselwitz B, Expert committee ‘Pacemaker’, Institute of Quality Assurance Hessen, Erdogan A, Funck R, Irnich W, Israel CW, Olbrich HG, Schmidt H, Sperzel J, Zegelman M. Do gender differences exist in pacemaker implantation?–results of an obligatory external quality control program. Europace. 2010;12:210–5. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical